Pmv Pharmaceuticals Inc (PMVP)

Finanzdaten der Pmv Pharmaceuticals Inc-Aktie (PMVP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	0.73%18.88	19.02	19.24	22.52	22.88
Research and Development	4.27%14.68	15.33	15.83	18.21	18.40
Operating Income/Loss	0.73%-18.88	-19.02	-19.24	-22.52	-22.88
Net Interest Income/Expense	19.59%0.79	0.98	1.23	1.48	1.69
Income/Loss From Continuing Operations Before Tax	0.25%-18.08	-18.04	-18.01	-21.07	-21.21
Income Tax Expense/Benefit	0.00	-	0.03	-0.01	0.01
	0.27%-18.09	-18.04	-18.04	-21.06	-21.21
Attributable To Parent	0.27%-18.09	-18.04	-18.04	-21.06	-21.21
Basic Average Shares	0.10%53.39	53.33	0.22	52.99	52.01
Diluted Average Shares	0.10%53.39	53.33	0.22	52.99	52.01
Basic Earnings Per Share	-0.34	-0.34	-0.34	-0.40	-0.41
Diluted Earnings Per Share	-0.34	-0.34	-0.34	-0.40	-0.41